Navigation Links
FDA: New Warnings Required on Use of Gadolinium-Based Contrast Agents
Date:9/9/2010

SILVER SPRING, Md., Sept. 9 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF), if the drug is administered to certain patients with kidney disease.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Three of the GBCAs – Magnevist, Omniscan, and Optimark – will be described as inappropriate for use among patients with acute kidney injury or chronic severe kidney disease. All GBCA labels will emphasize the need to screen patients to detect these types of kidney dysfunction before administration.

GBCAs are intravenous drugs approved by the FDA for use with magnetic resonance imaging or magnetic resonance angiography to help detect abnormalities of body organs, blood vessels, and other tissues.

NSF is a condition involving the formation of excess fibrous connective tissue in the skin, joints, eyes, and internal organs. Symptoms of NSF can include scaling, hardening and tightening of the skin, red or dark patches on the skin, and stiffness. NSF may lead to death, especially if it involves body organs.

The FDA's review of the safety of the most widely used GBCAs determined that Magnevist, Omniscan, and Optimark are associated with a greater risk than other GBCAs for NSF in certain patients with kidney disease. Data suggest that NSF may follow the administration of any GBCA and the FDA continues to assess the safety of each GBCA to better estimate its NSF risks.

"The FDA is requiring these labeling changes to enhance the safe use of gadolinium-based contrast agents, including avoidance of ce
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
2. PTCB Certification Required for Pharmacy Technician Employment by Department of Veterans Affairs
3. Should Any Vaccines Be Required for Children? Pros and Cons and Current Research at New ProCon.org Website
4. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
5. Miltenyi Biotec Announces Release of Viscover(TM) Preclinical Contrast Agents for in vivo Small Animal Imaging
6. Reportlinker Adds Clinical Laboratory Testing Volume 1: Reagents and Instruments
7. Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market
8. Federal Agents Seize FastSize Extenders and FastSize EQM™ Erectile Quality Monitors
9. VisEn Announces New ProSense® 750 FAST and Neutrophil Elastase™ 680 FAST Fluorescence Molecular Imaging Agents at European Molecular Imaging Meeting 2010
10. Epix Pharmaceuticals, Inc. Announces a Change in the May 28, 2010 Auction Sale of Epix Imaging Agents to June 22, 2010
11. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
(Date:9/19/2014)... 2014 Intarcia Therapeutics, Inc. today ... its lead candidate ITCA 650 (continuous subcutaneous delivery of ... HbA1c levels at the 50 th Annual Meeting ... (EASD). Data from the open-label, phase 3 FREEDOM-HBL (high ... in patients with poorly controlled type 2 diabetes. The ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... DIEGO, March 14, 2012 OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Cancer Institute in Santa Monica, CA, and Lakeland ... initiated as enrolling sites, and investigators are screening ...
... YORK, March 14, 2012 Reportlinker.com ... report is available in its catalogue: ... Market Outlook in BRICS (Brazil, Russia, ... http://www.reportlinker.com/p0796126/Respiratory-Devices-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Respiratory_Devices ...
Cached Medicine Technology:OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19
(Date:9/20/2014)... September 21, 2014 6 Minutes to ... fitness expert Craig Ballantyne that is showing men and women ... blast away stubborn body fat using simple 6-minute exercises and ... Michaels, prompting an investigative review. , “When it comes ... in vs. calories out for all people,” reports Michaels. “Metabolism ...
(Date:9/20/2014)... Melbourne, Australia (PRWEB) September 21, 2014 ... levels are contributing to greater waste treatment volumes. ... are increasingly diverting waste from landfill. According to ... decade, governments have implemented strategies aimed at reducing ... amount of waste recycled and recovered.” Still, a ...
(Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
(Date:9/20/2014)... Sept. 20, 2014 (HealthDay News) -- As flu season ... infection is to get a flu shot and a ... A primary care doctor can vaccinate people against the ... patients may have. Retail stores may provide flu shots ... advice, said Dr. Jorge Parada, medical director of infection ...
(Date:9/20/2014)... York (PRWEB) September 20, 2014 ... ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continue ... another insurer has announced plans to end coverage ... on its website last month, Harrisburg, Pennsylvania-based Capital ... November 1, 2014. The insurer said its decision ...
Breaking Medicine News(10 mins):Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3
... of MRSA that causes bloodstream infections is five times more ... resistance to the potent antibiotic drug vancomycin used to treat ... study found that 50 percent of the patients infected with ... of patients infected with other MRSA strains. The ...
... During Last Year,s ,One Million Tests, World AIDS Day ... Testing Goal by Testing 35,034 , PHNOM PENH, Cambodia, ... to test several million people for HIV in observance of ... 2009 campaign, AHF/Cambodia CARES will launch its inaugural testing effort ...
... be reserved for the most seriously ill, experts say , ... to fight anemia appears to double the risk of stroke ... their quality of life, a new study finds. , ... agent (ESA), is often prescribed for diabetic patients with chronic ...
... Oct. 30 Amgen (Nasdaq: AMGN ) today ... to Reduce Cardiovascular Events with Aranesp® Therapy), a large, ... with chronic kidney disease (CKD) not on dialysis, moderate ... in the New England Journal of Medicine ...
... Beach, CA; December 8, 2009 , NEEDHAM, Mass., Oct. ... a special event, Terminology Services Information Day, will be co-located ... on December 8, 2009. For more information and to register ... . , (Logo: http://www.newscom.com/cgi-bin/prnh/20090629/DC39325LOGO ...
... Oct. 30 A hospital group based in McAllen, ... to settle claims that it violated the False Claims Act, ... 2006, by paying illegal compensation to doctors in order to ... the Justice Department announced today. McAllen Hospitals L.P., d/b/a/ South ...
Cached Medicine News:Health News:Henry Ford Hospital study: A MRSA strain linked to high death rates 2Health News:Cambodia: World AIDS Day HIV Campaign, 'Testing Millions,' to Again Launch During Cambodia's National Water Festival 2Health News:Anemia Drug May Raise Stroke Risk in Kidney Patients 2Health News:Anemia Drug May Raise Stroke Risk in Kidney Patients 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 2Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 4Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 5Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 6Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 7Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 8Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 9Health News:OMG Announces Special Event: Terminology Services Information Day 2Health News:OMG Announces Special Event: Terminology Services Information Day 3Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 2Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 3
... Inserted into the punctal opening to ... collagen plugs provide temporary relief of ... precisely measured premium collagen, Used as ... occlusion, Available in standard and short ...
... head combined with a softer more flexible ... design simplifies insertion and the large anchor ... dislocation less likely. The inserter provides ... SOFT PLUG Silicone Plugs are removable. Available ...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain CS Leads. Navigate minimally angled veins with no tortuosity....
Medicine Products: